• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤多结节性对肝内胆管癌的预后影响。

Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma.

机构信息

Hepato-Pancreato-Biliary Surgery and Liver transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre-Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, 1, Avenue Molière, 67098, Strasbourg, France.

Department of Pathology, Hôpital de Hautepierre-Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.

出版信息

J Gastrointest Surg. 2019 Sep;23(9):1801-1809. doi: 10.1007/s11605-018-4052-y. Epub 2018 Nov 26.

DOI:10.1007/s11605-018-4052-y
PMID:30478531
Abstract

BACKGROUND

The prognostic value of tumor multinodularity in intrahepatic cholangiocarcinoma (ICC) remains debated. We aimed to evaluate the impact of tumor multinodularity according to the presence and distribution of multiples ICC's nodules.

METHODS

A retrospective review of a prospectively maintained database of patients undergoing resection for ICC from January 1995 to September 2017 was performed. Prognostic factors for survival were assessed by multivariate Cox analysis. Tumoral nodules were defined according to their number (single and multiple) and localization (satellites and contralateral).

RESULTS

Out of 120 selected patients, 64 (53%) had single and 56 (47%) had multiple lesions. Multiple lesions included tumors with satellites (n = 40; 71.5%) and tumors with contralateral lesions (n = 16; 28.5%). Patients with multiple tumors had significantly larger mean main lesion size (p = 0.02), required a higher rate of perioperative transfusion (p = 0.04), had a greater rate of lymph node involvement (p < 0.0001), vascular invasion (p = 0.04), and poor differentiation (p = 0.04) than single tumors. Patients with single tumors experienced a 5-year survival significantly longer (40%) than patients with multiple tumors (14%; p = 0.004). Patients having tumors with satellites had inferior median overall survival and 5-year survival rates (20 months, 7%) compared with patients with contralateral tumors (33.6 months, 29%) (p = 0.09). Multivariable analysis identified tumor multinodularity, morbidity, tumor size < 5 cm, poor differentiation, and lymph node involvement as independent prognostic factors for overall survival.

CONCLUSIONS

Tumor multinodularity represents an independent risk factor for survival in ICCs and identifies a category of patients in need of more effective perioperative treatment.

摘要

背景

肿瘤多结节性在肝内胆管细胞癌(ICC)中的预后价值仍存在争议。我们旨在根据多个 ICC 结节的存在和分布来评估肿瘤多结节性的影响。

方法

对 1995 年 1 月至 2017 年 9 月期间接受 ICC 切除术的患者前瞻性维护数据库进行了回顾性分析。通过多变量 Cox 分析评估生存的预后因素。肿瘤结节根据其数量(单发和多发)和定位(卫星灶和对侧)进行定义。

结果

在 120 名入选患者中,64 名(53%)为单发,56 名(47%)为多发。多发病变包括有卫星灶的肿瘤(n=40;71.5%)和有对侧病变的肿瘤(n=16;28.5%)。多发肿瘤的患者主病灶平均大小明显更大(p=0.02),需要更高的围手术期输血率(p=0.04),淋巴结受累率更高(p<0.0001)、血管侵犯(p=0.04)和低分化(p=0.04),与单发肿瘤相比。单发肿瘤患者的 5 年生存率显著更高(40%),而多发肿瘤患者的 5 年生存率(14%;p=0.004)。有卫星灶的肿瘤患者的中位总生存期和 5 年生存率(20 个月,7%)均低于有对侧肿瘤的患者(33.6 个月,29%)(p=0.09)。多变量分析确定肿瘤多结节性、发病率、肿瘤大小<5cm、低分化和淋巴结受累是总生存期的独立预后因素。

结论

肿瘤多结节性是 ICC 生存的独立危险因素,可识别出需要更有效的围手术期治疗的患者群体。

相似文献

1
Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma.肿瘤多结节性对肝内胆管癌的预后影响。
J Gastrointest Surg. 2019 Sep;23(9):1801-1809. doi: 10.1007/s11605-018-4052-y. Epub 2018 Nov 26.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.肝内胆管细胞癌多个肿瘤病灶切除术后的生存情况。
J Gastrointest Surg. 2019 Nov;23(11):2239-2246. doi: 10.1007/s11605-019-04184-2. Epub 2019 Mar 18.
4
Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.乙型肝炎病毒相关性肝内胆管癌切除术后的预后
World J Gastroenterol. 2015 Jan 21;21(3):935-43. doi: 10.3748/wjg.v21.i3.935.
5
Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience.欧洲肝内胆管癌的外科治疗:单中心经验
J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):131-7. doi: 10.1002/jhbp.158. Epub 2014 Aug 27.
6
[Diagnostic procedures and results in surgical therapy for cholangiocarcinoma].[胆管癌外科治疗的诊断程序与结果]
Zentralbl Chir. 2014 Dec;139 Suppl 2:e25-34. doi: 10.1055/s-0031-1283831. Epub 2012 Jan 24.
7
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.肝内胆管癌术后肝脏复发的预测因素
J Gastroenterol. 2006 Sep;41(9):893-900. doi: 10.1007/s00535-006-1877-z.
8
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
9
The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.肝内胆管癌患者手术治疗的影响及不良预后因素:60例患者的回顾性分析
Anticancer Res. 2008 Jul-Aug;28(4C):2353-9.
10
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.淋巴结转移对肝内胆管细胞癌手术预后的影响:日本肝胆胰外科学会肝脏外科学组的多中心分析。
J Hepatobiliary Pancreat Sci. 2011 May;18(3):443-52. doi: 10.1007/s00534-010-0349-2.

引用本文的文献

1
An explainable machine learning model for predicting the risk of distant metastasis in intrahepatic cholangiocarcinoma: a population-based cohort study.一种用于预测肝内胆管癌远处转移风险的可解释机器学习模型:一项基于人群的队列研究。
Discov Oncol. 2025 Jun 18;16(1):1140. doi: 10.1007/s12672-025-02952-y.
2
Prognostic significance of the number of hepatic lesions in multifocal intrahepatic cholangiocarcinoma after radical resection: an IPTW propensity-score analysis.根治性切除术后多灶性肝内胆管癌肝内病灶数量的预后意义:一项逆概率加权倾向评分分析
BMC Cancer. 2025 May 23;25(1):930. doi: 10.1186/s12885-025-13737-5.
3
Developing a Prognostic Model for Intrahepatic Cholangiocarcinoma Patients With Elevated Preoperative Carbohydrate Antigen 19-9 Levels: Volume-Adjusted CA19-9 (VACA) as a Novel Biomarker.

本文引用的文献

1
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery.肝内胆管细胞癌中单发性、卫星灶或多灶性肝结节分布模式:手术治疗后的预后影响。
Ann Surg Oncol. 2018 Nov;25(12):3719-3727. doi: 10.1245/s10434-018-6669-1. Epub 2018 Aug 7.
2
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.术前风险评分与肝内胆管细胞癌肝切除术后长期预后的预测。
J Am Coll Surg. 2018 Apr;226(4):393-403. doi: 10.1016/j.jamcollsurg.2017.12.011. Epub 2017 Dec 21.
3
Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.
为术前糖类抗原19-9水平升高的肝内胆管癌患者建立预后模型:体积校正CA19-9(VACA)作为一种新型生物标志物
Cancer Control. 2025 Jan-Dec;32:10732748251317692. doi: 10.1177/10732748251317692.
4
Management of intrahepatic cholangiocarcinoma: a review for clinicians.肝内胆管癌的管理:临床医生综述
Gastroenterol Rep (Oxf). 2025 Jan 26;13:goaf005. doi: 10.1093/gastro/goaf005. eCollection 2025.
5
MRI-based microvascular invasion prediction in mass-forming intrahepatic cholangiocarcinoma: survival and therapeutic benefit.基于MRI的肿块型肝内胆管癌微血管侵犯预测:生存及治疗获益情况
Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11296-0.
6
Mass-forming intrahepatic cholangiocarcinoma: treatment outcomes after curative-intent resection in an Australian tertiary referral hospital.肿块型肝内胆管癌:澳大利亚一家三级转诊医院根治性切除术后的治疗结果
ANZ J Surg. 2025 May;95(5):934-941. doi: 10.1111/ans.19326. Epub 2024 Dec 6.
7
A preliminary study of developing an MRI-based model for postoperative recurrence prediction and treatment direction of intrahepatic cholangiocarcinoma.基于磁共振成像(MRI)的肝内胆管癌术后复发预测及治疗方向模型开发的初步研究。
Radiol Med. 2024 Dec;129(12):1766-1777. doi: 10.1007/s11547-024-01910-y. Epub 2024 Nov 2.
8
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.肿瘤负担评分和癌胚抗原可预测肝切除术后肝内胆管细胞癌患者的结局:一项多机构分析。
BMC Cancer. 2024 Mar 20;24(1):358. doi: 10.1186/s12885-024-12091-2.
9
Predicting the microvascular invasion and tumor grading of intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance imaging radiomics and morphological features.基于磁共振成像放射组学和形态学特征预测肝内肿块型胆管癌的微血管侵犯和肿瘤分级
Quant Imaging Med Surg. 2023 Dec 1;13(12):8079-8093. doi: 10.21037/qims-23-11. Epub 2023 Sep 28.
10
Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.基于磁共振图像的肝内肿块型胆管癌患者微血管侵犯的预测因素
Abdom Radiol (NY). 2023 Apr;48(4):1306-1319. doi: 10.1007/s00261-023-03847-8. Epub 2023 Mar 5.
多灶性肝内胆管细胞癌行外科切除并不能改善生存:与动脉内治疗的比较。
Ann Surg Oncol. 2018 Jan;25(1):83-90. doi: 10.1245/s10434-017-6110-1. Epub 2017 Oct 23.
4
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.初始不可切除的肝内胆管癌的新辅助化疗。
Br J Surg. 2018 Jun;105(7):839-847. doi: 10.1002/bjs.10641. Epub 2017 Aug 31.
5
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.定义肝内胆管癌切除术后的长期生存者。
J Gastrointest Surg. 2017 Nov;21(11):1888-1897. doi: 10.1007/s11605-017-3550-7. Epub 2017 Aug 24.
6
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.美国癌症联合委员会第7版和第8版肝内胆管癌分期系统的比较性能
J Surg Oncol. 2017 May;115(6):696-703. doi: 10.1002/jso.24569. Epub 2017 Feb 14.
7
Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma.多中心研究:肝内胆管细胞癌肝切除术后发病率对长期生存的影响。
Br J Surg. 2016 Dec;103(13):1887-1894. doi: 10.1002/bjs.10296. Epub 2016 Sep 15.
8
First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma.原发性和复发性肝内胆管癌的初次及再次肝切除术
Am J Surg. 2016 Aug;212(2):221-9. doi: 10.1016/j.amjsurg.2015.07.016. Epub 2015 Oct 3.
9
Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma.肝内胆管细胞癌切除术后并发症对长期生存的影响。
Cancer. 2015 Aug 15;121(16):2730-9. doi: 10.1002/cncr.29419. Epub 2015 Apr 22.
10
Extended liver resections for intrahepatic cholangiocarcinoma: friend or foe?肝内胆管癌扩大肝切除术:是福是祸?
Surgery. 2015 Apr;157(4):656-65. doi: 10.1016/j.surg.2014.11.011. Epub 2015 Feb 20.